Discover how sialylation status determines cell susceptibility to amyloid toxicity in neurodegenerative diseases like Alzheimer's and Parkinson's.
New research reveals that shifts in brain glucose metabolism act as a 'stopwatch' for MSA progression, mapping destruction years before clinical symptoms worsen.